Skip to main content
. Author manuscript; available in PMC: 2016 Jul 22.
Published in final edited form as: Clin Cancer Res. 2015 Mar 9;21(11):2558–2568. doi: 10.1158/1078-0432.CCR-14-2506

Figure 4.

Figure 4

Evaluation of ABT-263 in RS4;11 xenografts or sublines treated with SAR405838. A, Representative RS4;11 sublines were treated with ABT-263 for 24 h and biochemical markers of apoptosis were analyzed by immunoblotting. B, RS4;11 parental and sublines were treated with ABT-263 for 4 days and cell viability was determined by a WST assay. C, Cells were treated with ABT-263 for 24 h for apoptosis analysis by flow cytometry with Annexin V/P.I. double staining.